Clinical Trial Update: Lymph Node Ratio and Kras Mutation in R Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lymph node ratio and KRAS mutation in colon cancer (Stage III) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Mansoura University | Conditions: Colon Cancer Stage III | Phase 3 | Status: COMPLETED